Inventor
JIN HAOLUN
US39 patents
⚠️ This page may combine multiple inventors who share the name “JIN HAOLUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
27 patentsUS9216996B2Dec 22, 2015
Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepines and methods for treating viral infections
GILEAD SCIENCES INC67 citations98
US9139604B2Sep 22, 2015
Antiviral phosphonate analogs
GILEAD SCIENCES INC42 citations97
US8871785B2Oct 28, 2014
Antiviral phosphonate analogs
GILEAD SCIENCES INC49 citations97
US8022083B2Sep 20, 2011
Antiviral phosphonate analogs
GILEAD SCIENCES INC46 citations97
US7645747B2Jan 12, 2010
Therapeutic phosphonate compounds
GILEAD SCIENCES INC60 citations97
US9663528B2May 30, 2017
Substituted 1,2,3,4,6,8,12,12a-octahydro-1,4-methanodipyrido[1,2-a:1',2'-d]pyrazines and methods for treating viral infections
GILEAD SCIENCES INC11 citations93
US10035809B2Jul 31, 2018
Substituted 2,3,4,5,7,9,13,13a-octahydro-1,5-methanopyrido[1′,2′:4,5]pyrazino[1,2-a][1,3]diazepines and methods for treating viral infections
GILEAD SCIENCES INC10 citations92
US9732092B2Aug 15, 2017
Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]OXAZEPINES and methods for treating viral infections
GILEAD SCIENCES INC11 citations92
US9522912B2Dec 20, 2016
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
GILEAD SCIENCES INC21 citations92
US7429565B2Sep 30, 2008
Antiviral phosphonate analogs
GILEAD SCIENCES INC25 citations92
US7649015B2Jan 19, 2010
Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
GILEAD SCIENCES INC19 citations91
US9795602B2Oct 24, 2017
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
GILEAD SCIENCES INC4 citations84
US9630978B2Apr 25, 2017
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
GILEAD SCIENCES INC10 citations84
US7253180B2Aug 7, 2007
Pre-organized tricyclic integrase inhibitor compounds
GILEAD SCIENCES INC17 citations82
US11883397B2Jan 30, 2024
Substituted pyrido[1,2-a]pyrrolo[1,2-d]pyrazines for treating viral infections
GILEAD SCIENCES INC1 citations73
US11213523B2Jan 4, 2022
Substituted pyrido[1,2-a]pyrrolo[1,2-d]pyrazines for treating viral infections
GILEAD SCIENCES INC1 citations73
US10689399B2Jun 23, 2020
Substituted 3,4,5,6,8,10,14,14a-octahydro-2h-2,6-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazocines and methods for treating viral infections
GILEAD SCIENCES INC2 citations73
US10456395B2Oct 29, 2019
Substituted dipyrido[1,2-a:1′,2′-d]pyrazines for treating viral infections
GILEAD SCIENCES INC1 citations73
US9458159B2Oct 4, 2016
Substituted pyrido[1′,2′:4,5]pyrazino[1,2-a]azepines for treating viral infections
GILEAD SCIENCES INC1 citations63
US7462721B2Dec 9, 2008
Aza-quinolinol phosphonate integrase inhibitor compounds
GILEAD SCIENCES INC5 citations63
US12521388B2Jan 13, 2026
Substituted dipyrido[1,2-a:1′,2′-d]pyrazines for treating viral infections
GILEAD SCIENCES INC0 citations62
US11548901B2Jan 10, 2023
Substituted 1,4-methanopyrido[1′,2′:4,5]pyrazino[1,2-a]pyrimidines for treating viral infections
GILEAD SCIENCES INC0 citations62
US11253524B2Feb 22, 2022
Metabolites of bictegravir
GILEAD SCIENCES INC0 citations58
US8008287B2Aug 30, 2011
Integrase inhibitors
GILEAD SCIENCES INC2 citations58
US10646486B2May 12, 2020
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
GILEAD SCIENCES INC0 citations52
US7998950B2Aug 16, 2011
Antiviral compounds
GILEAD SCIENCES INC1 citations49
US10800772B2Oct 13, 2020
Therapeutic compounds
GILEAD SCIENCES INC0 citations41
IAF BIOCHEM INT
10 patentsUS5696254ADec 9, 1997
Processes for the diastereoselective synthesis of nucleoside analogues
IAF BIOCHEM INT93 citations97
US5466806ANov 14, 1995
Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
IAF BIOCHEM INT123 citations97
US5693787ADec 2, 1997
Intermediates in the synthesis of 1,3-oxathiolanyl cytosine nucleoside analogues
IAF BIOCHEM INT37 citations96
US5663320ASep 2, 1997
Processes for the diastereoselective separation of nucleoside analogue synthetic intermediates
IAF BIOCHEM INT35 citations96
US6175008B1Jan 16, 2001
Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
IAF BIOCHEM INT37 citations95
US5684164ANov 4, 1997
Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
IAF BIOCHEM INT60 citations95
US5587480ADec 24, 1996
Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
IAF BIOCHEM INT56 citations92
US5763606AJun 9, 1998
Stereoselective synthesis of nucleoside analogues using bicyclic intermediate
IAF BIOCHEM INT33 citations91
US6228860B1May 8, 2001
Substituted 1,3-oxathiolanes with antiviral properties
IAF BIOCHEM INT18 citations82
US6369066B1Apr 9, 2002
Substituted 1,3-oxathiolanes with antiviral properties
IAF BIOCHEM INT0 citations40